AAAAAA
Results: 101-125/15678
Authors:
Wolf, D
Schumann, J
Koerber, K
Kiemer, AK
Vollmar, AM
Sass, G
Papadopoulos, T
Bang, R
Klein, SD
Brune, B
Tiegs, G
Citation: D. Wolf et al., Low-molecular-weight hyaluronic acid induces nuclear factor-kappa B-dependent resistance against tumor necrosis factor alpha-mediated liver injury inmice, HEPATOLOGY, 34(3), 2001, pp. 535-547
Authors:
Herrera, B
Fernandez, M
Alvarez, AM
Roncero, C
Benito, M
Gil, J
Fabregat, I
Citation: B. Herrera et al., Activation of caspases occurs downstream from radical oxygen species production, Bcl-x(L) down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes, HEPATOLOGY, 34(3), 2001, pp. 548-556
Authors:
Mann, DV
Lam, WWM
Hjelm, NM
So, NMC
Yeung, DKW
Metreweli, C
Lau, WY
Citation: Dv. Mann et al., Human liver regeneration: Hepatic energy economy is less efficient when the organ is diseased, HEPATOLOGY, 34(3), 2001, pp. 557-565
Authors:
Ito, T
Yasui, K
Mukaigawa, J
Katsume, A
Kohara, M
Mitamura, K
Citation: T. Ito et al., Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: Establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system, HEPATOLOGY, 34(3), 2001, pp. 566-572
Authors:
Serfaty, L
Thabut, D
Zoulim, F
Andreani, T
Chazouilleres, O
Carbonell, N
Loria, A
Poupon, R
Citation: L. Serfaty et al., Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: Results ofa pilot study, HEPATOLOGY, 34(3), 2001, pp. 573-577
Authors:
de Man, RA
Wolters, LMM
Nevens, F
Chua, D
Sherman, M
Lai, CL
Gadano, A
Lee, Y
Mazzotta, F
Thomas, N
DeHertogh, D
Citation: Ra. De Man et al., Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection, HEPATOLOGY, 34(3), 2001, pp. 578-582
Authors:
Liu, CJ
Chen, PJ
Lai, MY
Kao, JH
Chen, DS
Citation: Cj. Liu et al., Hepatitis B virus variants in patients receiving lamivudine treatment withbreakthrough hepatitis evaluated by serial viral loads and full-length viral sequences, HEPATOLOGY, 34(3), 2001, pp. 583-589
Authors:
Orito, E
Ichida, T
Sakugawa, H
Sata, M
Horiike, N
Hino, K
Okita, K
Okanoue, T
Iino, S
Tanaka, E
Suzuki, K
Watanabe, H
Hige, S
Mizokami, M
Citation: E. Orito et al., Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan, HEPATOLOGY, 34(3), 2001, pp. 590-594
Authors:
Seeff, LB
Lindsay, KL
Bacon, BR
Kresina, TF
Hoofnagle, JH
Citation: Lb. Seeff et al., Complementary and alternative medicine in chronic liver disease, HEPATOLOGY, 34(3), 2001, pp. 595-603
Authors:
Bolondi, L
Gaiani, S
Celli, N
Piscaglia, F
Citation: L. Bolondi et al., Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma, HEPATOLOGY, 34(3), 2001, pp. 608-608
Authors:
Livraghi, T
Citation: T. Livraghi, Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma, HEPATOLOGY, 34(3), 2001, pp. 608-609
Authors:
Goldberg, SN
Solbiati, L
Citation: Sn. Goldberg et L. Solbiati, Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma, HEPATOLOGY, 34(3), 2001, pp. 609-609
Authors:
de Sio, I
Castellano, L
De Girolamo, V
di Santolo, SS
Marone, A
Blanco, CD
Marone, G
Citation: I. De Sio et al., Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma, HEPATOLOGY, 34(3), 2001, pp. 609-610
Authors:
Llovet, JM
Vilana, R
Bru, C
Bianchi, L
Bruix, J
Citation: Jm. Llovet et al., Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma - Reply, HEPATOLOGY, 34(3), 2001, pp. 610-611
Authors:
Yeung, LTF
King, SM
Roberts, EA
Citation: Ltf. Yeung et al., Mother-to-infant transmission of hepatitis C virus, HEPATOLOGY, 34(2), 2001, pp. 223-229
Authors:
Kernebeck, T
Lohse, AW
Grotzinger, J
Citation: T. Kernebeck et al., A bioinformatical approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen/liver pancreas, HEPATOLOGY, 34(2), 2001, pp. 230-233
Authors:
Bertolotti, M
Carulli, L
Concari, M
Martella, P
Loria, P
Tagliafico, E
Ferrari, S
Del Puppo, M
Amati, B
De Fabiani, E
Crestani, M
Amorotti, C
Manenti, A
Carubbi, F
Pinetti, A
Carulli, N
Citation: M. Bertolotti et al., Suppression of bile acid synthesis, but not of hepatic cholesterol 7 alpha-hydroxylase expression, by obstructive cholestasis in humans, HEPATOLOGY, 34(2), 2001, pp. 234-242
Authors:
Miyakawa, H
Tanaka, A
Kikuchi, K
Matsushita, M
Kitazawa, E
Kawaguchi, N
Fujikawa, H
Gershwin, ME
Citation: H. Miyakawa et al., Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens, HEPATOLOGY, 34(2), 2001, pp. 243-248
Authors:
Chung, CH
Gottstein, J
Blei, AT
Citation: Ch. Chung et al., Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis, HEPATOLOGY, 34(2), 2001, pp. 249-254
Short-term prognosis in critically ill patients with cirrhosis assessed byprognostic scoring systems
Authors:
Wehler, M
Kokoska, J
Reulbach, U
Hahn, EG
Strauss, R
Citation: M. Wehler et al., Short-term prognosis in critically ill patients with cirrhosis assessed byprognostic scoring systems, HEPATOLOGY, 34(2), 2001, pp. 255-261
Authors:
Columbano, A
Ledda-Columbano, GM
Pibiri, M
Concas, D
Reddy, JK
Rao, MS
Citation: A. Columbano et al., Peroxisome proliferator-activated receptor-alpha(-/-) mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor, HEPATOLOGY, 34(2), 2001, pp. 262-266
Authors:
Kokudo, N
Tada, K
Seki, M
Ohta, H
Azekura, K
Ueno, M
Ohta, K
Yamaguchi, T
Matsubara, T
Takahashi, T
Nakajima, T
Muto, T
Ikari, T
Yanagisawa, A
Kato, Y
Citation: N. Kokudo et al., Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization, HEPATOLOGY, 34(2), 2001, pp. 267-272
Authors:
Chiaramonte, MG
Cheever, AW
Malley, JD
Donaldson, DD
Wynn, TA
Citation: Mg. Chiaramonte et al., Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis, HEPATOLOGY, 34(2), 2001, pp. 273-282
Authors:
Benhamou, Y
Di Martino, V
Bochet, M
Colombet, G
Thibault, V
Liou, A
Katlama, C
Poynard, T
Citation: Y. Benhamou et al., Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy, HEPATOLOGY, 34(2), 2001, pp. 283-287
Authors:
Ikejima, K
Honda, H
Yoshikawa, M
Hirose, M
Kitamura, T
Takei, Y
Sato, N
Citation: K. Ikejima et al., Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals, HEPATOLOGY, 34(2), 2001, pp. 288-297